Skip to content

Apyx Medical Corporation APYX Deferred revenue, net of current portion

Deferred revenue, net of current portion at other companies

Ametek logo
AmetekAME
$41.8M+5.3%
MicroStrategy logo
MicroStrategyMSTR
$5.22M+31.2%
Torrid Holdings logo
Torrid HoldingsCURV
$200K-33.3%
Tesla, Inc. logo
Tesla, Inc.TSLA
$3.85B+6.6%
Carrier Global logo
Carrier GlobalCARR
$208M+23.8%
SolarEdge Technologies logo
SolarEdge TechnologiesSEDG
$313.95M+28.9%

Other financials

Income statement

See full
Revenue$12.5M+32.4%
Gross profit$7.5M-19.2%
Operating income-$5.5M-349%
Net income-$2.1M+48.6%
EPS (diluted)-$0.19-533%

Balance sheet

See full
Cash & equivalents$31.1M+0.4%
Total debt$39.5M+1.4%
Total equity$12.8M+22.1%
Total assets$63.0M+4.8%

Cash flow

See full
Operating cash flow-$572.0K+18.5%
CapEx$60.0K+9.1%
Free cash flow-$632.0K+16.5%

Valuation

See full
Market cap$181.07M+114%
Enterprise value$189.4M+101%
P/S3.2×+1.4×

Profitability

See full
Gross margin61.9%-3.1pp
Operating margin-46%+9.9pp
Net margin-16.2%-6.2pp
FCF margin-16.1%-4.8pp

Returns & leverage

See full
Return on equity-77.8%-22.4pp
Debt / equity3.1×-0.6×
Current ratio5.8×+0.3×

Where this comes from

Reported directly by Apyx Medical Corporation in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: Apyx Medical Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Apyx Medical Corporation's deferred revenue, net of current portion.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Apyx Medical Corporation's deferred revenue, net of current portion?
Apyx Medical Corporation (APYX) reported deferred revenue, net of current portion of $1.13M in Q1 2026.
How has Apyx Medical Corporation's deferred revenue, net of current portion changed year-over-year?
Apyx Medical Corporation's deferred revenue, net of current portion decreased by 5.3% year-over-year, from $1.19M to $1.13M.
What is the long-term trend for Apyx Medical Corporation's deferred revenue, net of current portion?
Over 5 years (2020 to 2025), Apyx Medical Corporation's deferred revenue, net of current portion has grown at a 11.1% compound annual growth rate (CAGR), from $621K to $1.05M.